These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35226524)

  • 1. In advanced CKD with poorly controlled hypertension, chlorthalidone reduced BP at 12 wk.
    Crews DC
    Ann Intern Med; 2022 Mar; 175(3):JC29. PubMed ID: 35226524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorthalidone for Hypertension in Advanced CKD. Reply.
    Agarwal R; Sinha AD; Tu W
    N Engl J Med; 2022 Apr; 386(14):1384. PubMed ID: 35388681
    [No Abstract]   [Full Text] [Related]  

  • 3. In older adults with hypertension, chlorthalidone vs. hydrochlorothiazide did not reduce major CV events or deaths at 2.4 y.
    Bavishi C
    Ann Intern Med; 2023 Apr; 176(4):JC39. PubMed ID: 37011397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study.
    Agarwal R; Sinha AD; Pappas MK; Ammous F
    Am J Nephrol; 2014; 39(2):171-82. PubMed ID: 24526255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.
    Agarwal R; Cramer AE; Balmes-Fenwick M; Sinha AD; Ouyang F; Tu W
    Am J Nephrol; 2020; 51(7):542-552. PubMed ID: 32663820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
    Agarwal R; Sinha AD; Tu W
    Circulation; 2022 Aug; 146(9):718-720. PubMed ID: 36037270
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorthalidone for Hypertension in Advanced CKD.
    Elias R; Zatz R
    N Engl J Med; 2022 Apr; 386(14):1382-1383. PubMed ID: 35388679
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorthalidone for Hypertension in Advanced CKD.
    Lindner G; Ravioli S
    N Engl J Med; 2022 Apr; 386(14):1382. PubMed ID: 35388678
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorthalidone for Hypertension in Advanced CKD.
    Afsar B; Kanbay M; Elsurer Afsar R
    N Engl J Med; 2022 Apr; 386(14):1383-1384. PubMed ID: 35388680
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorthalidone in advanced CKD.
    Allison SJ
    Nat Rev Nephrol; 2022 Jan; 18(1):3. PubMed ID: 34819632
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease?
    Pitt B; Auchus RJ
    Hypertension; 2024 Jan; 81(1):107-109. PubMed ID: 37909173
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.
    Karadsheh F; Weir MR
    Curr Hypertens Rep; 2012 Oct; 14(5):416-20. PubMed ID: 22886538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
    Rahman M; Ford CE; Cutler JA; Davis BR; Piller LB; Whelton PK; Wright JT; Barzilay JI; Brown CD; Colon PJ; Fine LJ; Grimm RH; Gupta AK; Baimbridge C; Haywood LJ; Henriquez MA; Ilamaythi E; Oparil S; Preston R;
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):989-1002. PubMed ID: 22490878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazides in advanced chronic kidney disease: time for a randomized controlled trial.
    Sinha AD; Agarwal R
    Curr Opin Cardiol; 2015 Jul; 30(4):366-72. PubMed ID: 26049383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In CKD, dapagliflozin reduced a composite of eGFR decline, end-stage kidney disease, or CV or renal mortality.
    Molony DA; LeMaistre FI
    Ann Intern Med; 2021 Feb; 174(2):JC20. PubMed ID: 33524285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorthalidone and Advanced Chronic Kidney Disease.
    Furgeson SB; Linas S
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):1076-1078. PubMed ID: 35577563
    [No Abstract]   [Full Text] [Related]  

  • 18. In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
    Herrington WG; Staplin N
    Ann Intern Med; 2020 Aug; 173(4):JC16. PubMed ID: 32805175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.
    Moes AD; Hesselink DA; van den Meiracker AH; Zietse R; Hoorn EJ
    Am J Kidney Dis; 2017 Jun; 69(6):796-804. PubMed ID: 28259499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
    Herrington WG; Staplin N
    Ann Intern Med; 2020 Aug; 173(4):JC17. PubMed ID: 32805174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.